1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base, and Forecast Years Timeline
1.8. Key Benefits to the Stakeholder
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Research Processes
3. EXECUTIVE SUMMARY
3.1. Key Findings
3.2. Analyst View
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
4.5. Analyst View
5. BLOOD BAG MARKET BY PRODUCT TYPE
5.1. Introduction
5.2. Single Blood Bag
5.2.1. Market Opportunities and Trends
5.2.2. Growth Prospects
5.3. Double Blood Bag
5.3.1. Market Opportunities and Trends
5.3.2. Growth Prospects
5.4. Triple Blood Bag
5.4.1. Market Opportunities and Trends
5.4.2. Growth Prospects
5.5. Quadruple Blood Bag
5.5.1. Market Opportunities and Trends
5.5.2. Growth Prospects
5.6. Penta Blood Bag
5.6.1. Market Opportunities and Trends
5.6.2. Growth Prospects
6. BLOOD BAG MARKET BY CAPACITY
6.1. Introduction
6.2. Less than 250 ml
6.2.1. Market Opportunities and Trends
6.2.2. Growth Prospects
6.3. 250 ml - 500 ml
6.3.1. Market Opportunities and Trends
6.3.2. Growth Prospects
6.4. Above 500 ml
6.4.1. Market Opportunities and Trends
6.4.2. Growth Prospects
7. BLOOD BAG MARKET BY END-USER
7.1. Introduction
7.2. Hospitals
7.2.1. Market Opportunities and Trends
7.2.2. Growth Prospects
7.3. Diagnostic Centres
7.3.1. Market Opportunities and Trends
7.3.2. Growth Prospects
7.4. Clinical Research
7.4.1. Market Opportunities and Trends
7.4.2. Growth Prospects
7.5. Blood Banks
7.5.1. Market Opportunities and Trends
7.5.2. Growth Prospects
8. BLOOD BAG MARKET BY THERAPEUTIC AREA
8.1. Introduction
8.2. Oncology
8.2.1. Market Opportunities and Trends
8.2.2. Growth Prospects
8.3. Autoimmune Diseases
8.3.1. Market Opportunities and Trends
8.3.2. Growth Prospects
8.4. Metabolic Diseases
8.4.1. Market Opportunities and Trends
8.4.2. Growth Prospects
8.5. Cardiovascular Diseases
8.5.1. Market Opportunities and Trends
8.5.2. Growth Prospects
8.6. Neurology
8.6.1. Market Opportunities and Trends
8.6.2. Growth Prospects
8.7. Infectious Diseases
8.7.1. Market Opportunities and Trends
8.7.2. Growth Prospects
8.8. Others
8.8.1. Market Opportunities and Trends
8.8.2. Growth Prospects
9. BLOOD BAG MARKET BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. By Product Type
9.2.2. By Capacity
9.2.3. By End User
9.2.4. By Therapeutic Area
9.2.5. By Country
9.2.5.1. United States
9.2.5.1.1. Market Opportunities and Trends
9.2.5.1.2. Growth Prospects
9.2.5.2. Canada
9.2.5.2.1. Market Opportunities and Trends
9.2.5.2.2. Growth Prospects
9.2.5.3. Mexico
9.2.5.3.1. Market Opportunities and Trends
9.2.5.3.2. Growth Prospects
9.3. South America
9.3.1. By Product Type
9.3.2. By Capacity
9.3.3. By End User
9.3.4. By Therapeutic Area
9.3.5. By Country
9.3.5.1. Brazil
9.3.5.1.1. Market Opportunities and Trends
9.3.5.1.2. Growth Prospects
9.3.5.2. Argentina
9.3.5.2.1. Market Opportunities and Trends
9.3.5.2.2. Growth Prospects
9.3.5.3. Others
9.3.5.3.1. Market Opportunities and Trends
9.3.5.3.2. Growth Prospects
9.4. Europe
9.4.1. By Product Type
9.4.2. By Capacity
9.4.3. By End User
9.4.4. By Therapeutic Area
9.4.5. By Country
9.4.5.1. United Kingdom
9.4.5.1.1. Market Opportunities and Trends
9.4.5.1.2. Growth Prospects
9.4.5.2. Germany
9.4.5.2.1. Market Opportunities and Trends
9.4.5.2.2. Growth Prospects
9.4.5.3. France
9.4.5.3.1. Market Opportunities and Trends
9.4.5.3.2. Growth Prospects
9.4.5.4. Italy
9.4.5.4.1. Market Opportunities and Trends
9.4.5.4.2. Growth Prospects
9.4.5.5. Spain
9.4.5.5.1. Market Opportunities and Trends
9.4.5.5.2. Growth Prospects
9.4.5.6. Others
9.4.5.6.1. Market Opportunities and Trends
9.4.5.6.2. Growth Prospects
9.5. Middle East and Africa
9.5.1. By Product Type
9.5.2. By Capacity
9.5.3. By End User
9.5.4. By Therapeutic Area
9.5.5. By Country
9.5.5.1. Saudi Arabia
9.5.5.1.1. Market Opportunities and Trends
9.5.5.1.2. Growth Prospects
9.5.5.2. UAE
9.5.5.2.1. Market Opportunities and Trends
9.5.5.2.2. Growth Prospects
9.5.5.3. Others
9.5.5.3.1. Market Opportunities and Trends
9.5.5.3.2. Growth Prospects
9.6. Asia Pacific
9.6.1. By Product Type
9.6.2. By Capacity
9.6.3. By End User
9.6.4. By Therapeutic Area
9.6.5. By Country
9.6.5.1. Japan
9.6.5.1.1. Market Opportunities and Trends
9.6.5.1.2. Growth Prospects
9.6.5.2. China
9.6.5.2.1. Market Opportunities and Trends
9.6.5.2.2. Growth Prospects
9.6.5.3. India
9.6.5.3.1. Market Opportunities and Trends
9.6.5.3.2. Growth Prospects
9.6.5.4. South Korea
9.6.5.4.1. Market Opportunities and Trends
9.6.5.4.2. Growth Prospects
9.6.5.5. Taiwan
9.6.5.5.1. Market Opportunities and Trends
9.6.5.5.2. Growth Prospects
9.6.5.6. Thailand
9.6.5.6.1. Market Opportunities and Trends
9.6.5.6.2. Growth Prospects
9.6.5.7. Indonesia
9.6.5.7.1. Market Opportunities and Trends
9.6.5.7.2. Growth Prospects
9.6.5.8. Others
9.6.5.8.1. Market Opportunities and Trends
9.6.5.8.2. Growth Prospects
10. COMPETITIVE ENVIRONMENT AND ANALYSIS
10.1. Major Players and Strategy Analysis
10.2. Market Share Analysis
10.3. Mergers, Acquisitions, Agreements, and Collaborations
10.4. Competitive Dashboard
11. COMPANY PROFILES
11.1. Haemonetics Corporation
11.2. Terumo Blood and Cell Technologies
11.3. Macopharma USA
11.4. Fresnuise Kabi India Pvt., Ltd
11.5. Qingdao Sinoland International Trade Co.
11.6. Genesis BPS, BL Lifesciences
11.7. Mitra Industries Pvt. Ltd.
11.8. Suru International Pvt. Ltd.
11.9. B. Braun Melsungen AG (Germany)
11.10. HLL Lifecare Limited
11.11. Wego Group
11.12. Polymedicure Limited